3 Followers on Owler
Phenex develops novel proprietary small molecule drugs targeting nuclear receptors...
Read morePhenex develops novel proprietary small molecule drugs targeting nuclear receptors...
Read more
News
Nov 02, 2022
BioSpace
Phenex: OrsoBio Announces Acquisition of LXR Inverse Agonist Program for Treatment of Severe Dyslipidemias from Phenex Pharmaceuticals
Aug 02, 2018
BioPortfolio
Phenex: Phenex Pharmaceuticals AG Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 09052018 Prices from USD $250
May 11, 2018
BioPortfolio
Phenex: Phenex Pharmaceuticals AG Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14032018 Prices from USD $250
Sep 08, 2017
BioPortfolio
Phenex: Phenex Pharmaceuticals AG Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 24082017 Prices from USD $250
Jul 09, 2017
BioSpace
Phenex: Phenex Pharmaceuticals AG Announces Milestone Payment From Janssen Biotech For The Entry Of Rorgt Inhibitor Into Phase I
May 26, 2017
BioPortfolio
Phenex: Phenex Pharmaceuticals AG Pharmaceuticals Healthcare Deals and Alliances Profile Updated 12052017 Prices from USD $250
Mar 20, 2017
BioPortfolio
Phenex: Phenex Pharmaceuticals AG Pharmaceuticals Healthcare Deals and Alliances Profile Updated 21022017 Prices from USD $250
Jan 05, 2017
BioSpace
Phenex: Phenex Pharmaceuticals AG Receives $100M Milestone Payment From Gilead
Nov 28, 2016
BioPortfolio
Phenex Pharmaceuticals: Phenex Pharmaceuticals AG Mergers Acquisitions MA Partnerships Alliances and Investment Report Prices from USD $350
Nov 22, 2016
BioPortfolio
Phenex Pharmaceuticals: Phenex Pharmaceuticals AG Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250
Phenex Competitors
1
2
3
4
5
6
7
8
9
10
Looking for similar companies to Phenex?
Phenex News
Phenex Press Releases
Phenex Headquarters
Phenex Summary
ABOUT
Overview
Phenex develops novel proprietary small molecule drugs targeting nuclear receptors. Phenex was founded in 2002. Phenex's headquarters is located in Heidelberg, Baden-Württemberg, DE 69123. Phenex's Co-Founder & CEO, Claus Kremoser, currently has an a...CEO
Phenex's Co-Founder & CEO, Claus Kremoser, currently has an approval rating of 88%. Phenex's primary competitors are Pfizer, Novartis & AstraZeneca.Website
phenex-pharma.comCompetitors
View 21 Phenex competitors here.Acquisitions
There have been no acquisitions found related to PhenexFunding
View Phenex funding details.Investments
Recent investment data cannot be found related to PhenexFrequently Asked Questions about Phenex
When was Phenex founded?
Phenex was founded in 2002Who is Phenex's CEO?
Phenex's CEO is Claus KremoserHow much revenue does Phenex generate?
Phenex generates $39M in revenueHow much funding does Phenex have?
Phenex has historically raised $13.5M in funding
Where is Phenex's headquarters?
Phenex's headquarters is in Heidelberg Baden-Württemberg, DEHow many employees does Phenex have?
Phenex has 69 employeesWhat sector does Phenex operate in?
Phenex is in Biotechnology, PharmaceuticalsWho are Phenex's competitors?
Phenex's top competitors are Pfizer, Novartis, AstraZeneca